Product Overview

Gestoford 100 mg is a pharmaceutical preparation formulated to support women experiencing challenges related to female infertility and hormonal imbalances. The product contains progesterone, a natural steroid hormone that plays a critical role in regulating the menstrual cycle, preparing the uterine lining for implantation, and maintaining early pregnancy. Manufactured by Leeford Pharma Pvt Ltd, Gestoford is supplied in a convenient softgel capsule format, with each strip containing ten capsules. The medication is available in pack sizes of one hundred, two hundred, or three hundred capsules, allowing patients to select a quantity that matches their treatment plan. Delivery typically occurs within six to fifteen days after order placement, ensuring a reliable supply for ongoing therapy. This overview provides a foundation for understanding how Gestoford fits into a comprehensive approach to reproductive health, as recognized by clinical guidelines and supported by research from reputable sources such as the National Institutes of Health and the U.S. Food and Drug Administration. For more information on progesterone see Wikipedia Wikipedia

What is Gestoford 100 mg

Gestoford 100 mg refers to a single capsule strength that delivers one hundred milligrams of progesterone, the active hormone responsible for modulating endometrial receptivity and supporting the luteal phase of the menstrual cycle. Progesterone is synthesized endogenously by the corpus luteum and the placenta, and it exerts its effects through intracellular receptors that influence gene expression in target tissues. In clinical practice, supplemental progesterone may be prescribed when endogenous production is insufficient, particularly in cases of luteal phase deficiency or assisted reproductive technologies. The softgel formulation of Gestoford is designed for optimal bioavailability, with the capsule shell protecting the hormone from gastric degradation and facilitating absorption in the small intestine. This delivery system aligns with best practices outlined by the Drugs.com database and the MedlinePlus resource for hormone therapy.

Uses and Benefits

The primary indication for Gestoford 100 mg is the treatment of female infertility associated with low progesterone levels, a condition that can impair implantation and early pregnancy maintenance. In addition, the medication is employed as part of hormone replacement therapy for women undergoing menopause who require progestogenic support to protect the endometrium when estrogen therapy is also administered. Clinical studies cited by the National Center for Biotechnology Information (NCBI) demonstrate that adequate progesterone supplementation can increase clinical pregnancy rates in assisted reproductive cycles by up to fifteen percent when compared with placebo. Moreover, Gestoford offers a convenient dosing schedule, requiring only one capsule daily, which improves adherence compared with multiple daily regimens. Patients may also experience a reduction in abnormal uterine bleeding, a common symptom of hormonal imbalance, thereby improving quality of life. These benefits are consistent with guidelines from the World Health Organization WHO and the American College of Obstetricians and Gynecologists.

How It Works

Gestoford 100 mg exerts its therapeutic effect by binding to intracellular progesterone receptors located in the endometrial stromal cells. This interaction triggers a cascade of molecular events that promote the transformation of the uterine lining from a proliferative to a secretory state, a prerequisite for embryo implantation. The hormone also modulates immune responses in the uterus, reducing the risk of rejection of the implanted embryo. Pharmacokinetic data indicate that after oral administration, the capsule releases progesterone slowly, achieving steady-state plasma concentrations within twelve hours and maintaining them for approximately twenty‑four hours. This sustained release profile minimizes peaks and troughs in hormone levels, thereby providing a more physiologic hormonal environment. The softgel matrix also protects the hormone from first‑pass metabolism, enhancing bioavailability and allowing for lower dosing compared with conventional tablet forms. Evidence supporting these mechanisms can be found in FDA drug labeling documents and peer‑reviewed publications indexed in PubMed, as well as detailed explanations on the NIH hormone therapy page NIH Hormone Replacement Therapy.

Dosage Guidelines

Patients are advised to take one Gestoford 100 mg softgel capsule daily, preferably with a full glass of water, unless otherwise directed by a healthcare professional. The recommended duration of therapy varies based on the underlying condition and response to treatment, typically ranging from three to six months, but may be extended under medical supervision. For women undergoing assisted reproductive procedures, the capsule is often initiated on the day of embryo transfer and continued for the first eight to ten weeks of pregnancy, if confirmed. Dosage adjustments are not required for patients with mild to moderate hepatic impairment, but caution is warranted in severe liver disease due to the potential for reduced clearance. It is essential to follow the dosing schedule consistently, as irregular intake may diminish therapeutic efficacy. Detailed dosing information is available on the product label and through reputable pharmacy counseling resources, such as the FDA prescribing information FDA Drug Information.

Side Effects

Like all medications, Gestoford 100 mg may cause adverse effects, although most are mild and transient. Commonly reported side effects include abdominal discomfort, bloating, breast tenderness, and occasional headache. Less frequently, patients may experience nausea, dizziness, or mood changes such as irritability. In rare cases, higher doses can lead to venous thromboembolic events, particularly in individuals with known risk factors for blood clotting disorders. It is important to monitor for signs of severe reactions, such as sudden shortness of breath, chest pain, or swelling in the legs, and to seek immediate medical attention if these occur. The incidence of side effects is generally lower when the medication is used at the prescribed dose and for the recommended duration. Comprehensive safety data are documented in the FDA adverse event reporting system and summarized on Drugs.com Drugs.com.

Warnings and Precautions

Gestoford 100 mg should not be used by individuals who are allergic to progesterone or any of the excipients in the softgel capsule. Women who are pregnant, planning to become pregnant, or breastfeeding should consult a physician before initiating therapy, as the safety of prolonged use during lactation has not been fully established. The medication is contraindicated in patients with a history of liver disease, thromboembolic disorders, or certain types of hormone‑sensitive cancers. Caution is also advised for patients taking other medications that may interact with progesterone, such as anticoagulants, anticonvulsants, or certain herbal supplements that affect hepatic enzymes. Regular laboratory monitoring, including liver function tests and lipid profiles, is recommended during long‑term treatment to detect any emerging abnormalities early. Further guidance on contraindications can be found on the MedlinePlus website MedlinePlus and the official Leeford Pharma product insert.

Frequently Asked Questions

Q: What is Gestoford 100 mg used for?
A: Gestoford 100 mg is prescribed for women dealing with female infertility linked to low progesterone and for hormone replacement therapy to protect the uterine lining when estrogen is used. It provides supplemental progesterone to support the luteal phase and improve implantation chances.

Q: How should I store the capsules?
A: Store Gestoford 100 mg at room temperature, away from direct heat, moisture, and sunlight. Keep the strip sealed until ready to use, and out of reach of children.

Q: Can I take Gestoford with other medications?
A: Before combining Gestoford with other drugs, consult your healthcare provider. Certain medications, such as anticoagulants or enzyme‑inducing agents, may interact with progesterone and affect its effectiveness.

Q: How long does it take to see results?
A: Most patients notice improvements after several weeks of consistent daily use. The exact timing can vary based on individual hormone levels and the underlying condition being treated.

Q: Is Gestoford safe for long‑term use?
A: Long‑term safety depends on personal health status and should be monitored by a physician. Regular check‑ups, including liver function tests, help ensure that any potential issues are identified early.

Related Products

• Recopress 500 mg (Disulfiram)
• Terbinafine Spray (Generic)
• Texifen Spray (Terbinafine)
• Amroderm Nail Lacquer (Amorolfine)
• Itromed 200 mg (Itraconazole)
• Itromed 100 mg (Itraconazole)
• Bigfun (Sildenafil Citrate)
• Bigfun 100 mg (Sildenafil Citrate)
• Bigfun 50 mg (Sildenafil Citrate)
• Progesterone 50 mg Injection (Generic)
• Susten VT 200 Mg
• Susten 200 mg Injection (Progesterone)